Literature DB >> 31598101

Management of Calcium Channel Blocker Toxicity in the Pediatric Patient.

Jenna W Bartlett, Pamela L Walker.   

Abstract

Calcium channel blockers (CCBs) are commonly prescribed cardiovascular medications used in several disease states including hypertension, coronary artery disease, and atrial fibrillation. Inadvertent exposure or intentional overdose of CCBs may result in hypotension, bradycardia, dysrhythmias, conduction disturbances, and hyperglycemia. In the most severe cases, CCB toxicity can lead to rapid cardiovascular collapse. Given the risk of significant morbidity and mortality associated with CCB toxicity, it is important that health care professionals are able to recognize and treat patients who present with a potentially toxic ingestion. Due to the paucity of literature in managing pediatric patients with severe CCB toxicity, treatment strategies for pediatric patients are mostly limited to case reports and extrapolation from expert consensus recommendations for adults. All pediatric patients with a potentially toxic CCB ingestion should be evaluated in the emergency department. Activated charcoal may be considered for asymptomatic patients presenting within an hour of ingestion. Symptomatic patients should be placed under cardiac monitoring and treatments to stabilize the patient's hemodynamics should not be delayed. Traditional first-line IV therapies include small boluses of fluids, calcium, and vasopressors. High-dose insulin has been proposed to independently increase inotropy and improve CCB-induced hypoinsulinemia and insulin resistance that results from CCB inhibition of insulin release from pancreatic β-islet cells. High-dose insulin is recommended as first-line therapy for adults and shows promising efficacy and safety in several pediatric case reports. Intravenous lipid emulsion may be considered in patients who are refractory to first-line therapies, although the data for pediatric patients are extremely limited. Copyright Published by the Pediatric Pharmacy Advocacy Group. All rights reserved. For permissions, email: matthew.helms@ppag.org 2019.

Entities:  

Keywords:  antidotes; calcium channel blockers; drug overdose; fat emulsions; intravenous; poisoning; toxicity

Year:  2019        PMID: 31598101      PMCID: PMC6782123          DOI: 10.5863/1551-6776-24.5.378

Source DB:  PubMed          Journal:  J Pediatr Pharmacol Ther        ISSN: 1551-6776


  46 in total

Review 1.  Calcium channel blocker toxicity.

Authors:  Anna Maria Arroyo; Louise W Kao
Journal:  Pediatr Emerg Care       Date:  2009-08       Impact factor: 1.454

Review 2.  Position paper update: gastric lavage for gastrointestinal decontamination.

Authors:  B E Benson; K Hoppu; W G Troutman; R Bedry; A Erdman; J Höjer; B Mégarbane; R Thanacoody; E M Caravati
Journal:  Clin Toxicol (Phila)       Date:  2013-02-18       Impact factor: 4.467

3.  Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.

Authors:  O Lapatto-Reiniluoto; K T Kivistö; P J Neuvonen
Journal:  Clin Pharmacol Ther       Date:  2001-09       Impact factor: 6.875

4.  Near fatal case of amlodipine poisoning in an infant.

Authors:  Somashekhar M Nimbalkar; Dipen Vasudev Patel
Journal:  Indian J Pediatr       Date:  2012-07-25       Impact factor: 1.967

5.  Amlodipine (150 mg) Poisoning: A Case Study.

Authors:  Annu Raj; Prasan Kumar Panda; Shiv Shankar Singh
Journal:  Curr Drug Saf       Date:  2018

6.  Fatal nifedipine ingestions in children.

Authors:  D C Lee; T Greene; T Dougherty; P Pearigen
Journal:  J Emerg Med       Date:  2000-11       Impact factor: 1.484

Review 7.  Management of calcium channel antagonist overdose.

Authors:  Steven D Salhanick; Michael W Shannon
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

8.  Relative safety of hyperinsulinaemia/euglycaemia therapy in the management of calcium channel blocker overdose: a prospective observational study.

Authors:  Shaun L Greene; Indika Gawarammana; David M Wood; Alison L Jones; Paul I Dargan
Journal:  Intensive Care Med       Date:  2007-07-11       Impact factor: 17.440

9.  High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock.

Authors:  Joel S Holger; Samuel J Stellpflug; Jon B Cole; Carson R Harris; Kristin M Engebretsen
Journal:  Clin Toxicol (Phila)       Date:  2011-08-08       Impact factor: 4.467

10.  Experts Consensus Recommendations for the Management of Calcium Channel Blocker Poisoning in Adults.

Authors:  Maude St-Onge; Kurt Anseeuw; Frank Lee Cantrell; Ian C Gilchrist; Philippe Hantson; Benoit Bailey; Valéry Lavergne; Sophie Gosselin; William Kerns; Martin Laliberté; Eric J Lavonas; David N Juurlink; John Muscedere; Chen-Chang Yang; Tasnim Sinuff; Michael Rieder; Bruno Mégarbane
Journal:  Crit Care Med       Date:  2017-03       Impact factor: 7.598

View more
  3 in total

1.  Heart Rhythm Abnormalities Following Acute Verapamil Overdose.

Authors:  Utkarsh Kohli; Stephanie Lam; Hunter Eason; Priti Jani
Journal:  Indian J Pediatr       Date:  2020-10-02       Impact factor: 1.967

2.  Single-Pass Albumin Dialysis as Rescue Therapy for Pediatric Calcium Channel Blocker Overdose.

Authors:  Jenna Essink; Sydney Berg; Jaka Montange; Andrew Sankey; Veronica Taylor; Jeffrey Salomon
Journal:  J Investig Med High Impact Case Rep       Date:  2022 Jan-Dec

Review 3.  Calcium Channel Blocker Toxicity: A Practical Approach.

Authors:  Omar A Alshaya; Arwa Alhamed; Sara Althewaibi; Lolwa Fetyani; Shaden Alshehri; Fai Alnashmi; Shmeylan Alharbi; Mohammed Alrashed; Saleh F Alqifari; Abdulrahman I Alshaya
Journal:  J Multidiscip Healthc       Date:  2022-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.